SCLN

Sciclone Pharmaceuticals Inc
SCLN

Overview Fund Activity
Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

142 hedge funds and large institutions have $431M invested in Sciclone Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 54 reducing their positions, and 14 closing their positions.

Holders
142
Holders Change
+9
Holders Change %
+6.77%
% of All Funds
3.79%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
26
Increased
45
Reduced
54
Closed
14
Calls
–
Puts
$324K
Net Calls
-$324K
Net Calls Change
-$390K

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$22.3M
2
SCM
2
Stonepine Capital Management
Oregon
$22.5M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$10.3M
4
Millennium Management
4
Millennium Management
New York
$8.13M
5
CS
5
Credit Suisse
Switzerland
$3.34M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$5.69M
2
Skandinaviska Enskilda Banken (SEB)
2
Skandinaviska Enskilda Banken (SEB)
Sweden
$4.51M
3
BIT
3
BlackRock Institutional Trust
California
$20.7M
4
TC
4
TFS Capital
Pennsylvania
$434K
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$7.72M
Name Market Value Shares Shares
Change 		Shares
Change %
DC
151
Davenport & Co
Virginia
– – -11,400 Closed
QI
152
Quotient Investors
New York
– – -10,391 Closed
BA
153
Boston Advisors
Massachusetts
– – -10,373 Closed
BNP Paribas Financial Markets
154
BNP Paribas Financial Markets
France
– – -9,340 Closed
TRCT
155
Tower Research Capital (TRC)
New York
$0 38 -5,912 -99%
IA
156
IFP Advisors
Florida
– – -500 Closed
Group One Trading
157
Group One Trading
Illinois
– – – –
3 4 5 6
7